|
[1]
|
Dopazo, C., Søreide, K., Rangelova, E., Mieog, S., Carrion-Alvarez, L., Diaz-Nieto, R., et al. (2024) Hepatocellular Carcinoma. European Journal of Surgical Oncology, 50, Article ID: 107313. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Kauffmann, R. and Fong, Y. (2014) Posthepatectomy Liver Failure. Hepatobiliary Surgery and Nutrition, 3, 238-246.
|
|
[3]
|
Søreide, J.A. and Deshpande, R. (2021) Post Hepatectomy Liver Failure (PHLF)—Recent Advances in Prevention and Clinical Management. European Journal of Surgical Oncology, 47, 216-224. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Baumgartner, R., Gilg, S., Björnsson, B., Hasselgren, K., Ghorbani, P., Sauter, C., et al. (2022) Impact of Post-Hepatectomy Liver Failure on Morbidity and Short-and Long-Term Survival after Major Hepatectomy. BJS Open, 6, zrac097.
|
|
[5]
|
Kang, C.M., Ku, H.J., Moon, H.H., Kim, S., Jo, J.H., Choi, Y.I., et al. (2024) Predicting Safe Liver Resection Volume for Major Hepatectomy Using Artificial Intelligence. Journal of Clinical Medicine, 13, Article 381. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Lei, Z., Cheng, N., Si, A., Yang, P., Guo, G., Ma, W., et al. (2022) A Novel Nomogram for Predicting Postoperative Liver Failure after Major Hepatectomy for Hepatocellular Carcinoma. Frontiers in Oncology, 12, Article 817895. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Wang, J.J., Feng, J., Gomes, C., Calthorpe, L., Ashraf Ganjouei, A., Romero-Hernandez, F., et al. (2023) Development and Validation of Prediction Models and Risk Calculators for Posthepatectomy Liver Failure and Postoperative Complications Using a Diverse International Cohort of Major Hepatectomies. Annals of Surgery, 278, 976-984. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Allaire, M., Goumard, C., Lim, C., Le Cleach, A., Wagner, M. and Scatton, O. (2020) New Frontiers in Liver Resection for Hepatocellular Carcinoma. JHEP Reports, 2, Article ID: 100134. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Li, Y.R., Chen, J.D., Huang, J., et al. (2022) Post-Hepatectomy Liver Failure Prediction and Prevention: Development of a Nomogram Containing Postoperative Anticoagulants as a Risk Factor. Annals of Hepatology, 27, Article ID: 100744. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Ye, J.Z., Lu, H.Z., Zeng, C., et al. (2024) A Novel Surgical Scheme for Hepatectomy in Hepatocellular Carcinoma Patients with Clinically Significant Portal Hypertension. BMC Cancer, 24, Article No. 764. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
EOF Research (2012) EASL-EORTC Clinical Practice Guidelines: Management of Hepatocellular Carcinoma. European Journal of Cancer, 48, 599-641.
|
|
[12]
|
Marrero, J.A., Kulik, L.M., Sirlin, C.B., Zhu, A.X., Finn, R.S., Abecassis, M.M., et al. (2018) Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases. Hepatology, 68, 723-750. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Elder, R.W., McCabe, N.M., Hebson, C., Veledar, E., Romero, R., Ford, R.M., et al. (2013) Features of Portal Hypertension Are Associated with Major Adverse Events in Fontan Patients: The VAST Study. International Journal of Cardiology, 168, 3764-3769. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Zafar, F., Lubert, A.M., Trout, A.T., Katz, D.A., Palermo, J.J., Opotowsky, A.R., et al. (2022) Abdominal CT and MRI Findings of Portal Hypertension in Children and Adults with Fontan Circulation. Radiology, 303, 557-565. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Johnson, P.J., Berhane, S., Kagebayashi, C., Satomura, S., Teng, M., Reeves, H.L., et al. (2015) Assessment of Liver Function in Patients with Hepatocellular Carcinoma: A New Evidence-Based Approach—The ALBI Grade. Journal of Clinical Oncology, 33, 550-558. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Freeman, R.B. (2008) Model for End-Stage Liver Disease (MELD) for Liver Allocation: A 5-Year Score Card. Hepatology, 47, 1052-1057. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Sonneveld, M.J., Brouwer, W.P., Chan, H.L., Piratvisuth, T., Jia, J., Zeuzem, S., et al. (2019) Optimisation of the Use of APRI and FIB-4 to Rule Out Cirrhosis in Patients with Chronic Hepatitis B: Results from the SONIC-B Study. The Lancet Gastroenterology & Hepatology, 4, 538-544. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Rahbari, N.N., Garden, O.J., Padbury, R., Brooke-Smith, M., Crawford, M., Adam, R., et al. (2011) Posthepatectomy Liver Failure: A Definition and Grading by the International Study Group of Liver Surgery (ISGLS). Surgery, 149, 713-724. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Simonetto, D.A., Liu, M. and Kamath, P.S. (2019) Portal Hypertension and Related Complications: Diagnosis and Management. Mayo Clinic Proceedings, 94, 714-726. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Kim, M.Y., Baik, S.K. and Lee, S.S. (2010) Hemodynamic Alterations in Cirrhosis and Portal Hypertension. The Korean Journal of Hepatology, 16, 347-352. [Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
Wang, J., Zhang, Z., Shang, D., Liao, Y., Yu, P., Li, J., et al. (2022) A Novel Nomogram for Prediction of Post-Hepatectomy Liver Failure in Patients with Resectable Hepatocellular Carcinoma: A Multicenter Study. Journal of Hepatocellular Carcinoma, 9, 901-912. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
马帅, 赵卫, 刘敏, 等. 基于四维血流磁共振成像的肝硬化门静脉血流动力学研究[J]. 临床放射学杂志, 2025, 44(3): 465-471.
|
|
[23]
|
Iwakiri, Y. (2014) Pathophysiology of Portal Hypertension. Clinics in Liver Disease, 18, 281-291. [Google Scholar] [CrossRef] [PubMed]
|
|
[24]
|
Seo, Y.S. and Shah, V.H. (2012) The Role of Gut-Liver Axis in the Pathogenesis of Liver Cirrhosis and Portal Hypertension. Clinical and Molecular Hepatology, 18, 337-346. [Google Scholar] [CrossRef] [PubMed]
|
|
[25]
|
闫雨竹, 边杰. 基于增强CT的非侵入性成像标志物在预测肝硬化患者肝脏相关事件中的研究进展[J]. 临床放射学杂志, 2022, 41(11): 2142-2145.
|
|
[26]
|
Navarro, J.G., Yang, S.J., Kang, I., Choi, G.H., Han, D.H., Kim, K.S., et al. (2020) What Are the Most Important Predictive Factors for Clinically Relevant Posthepatectomy Liver Failure after Right Hepatectomy for Hepatocellular Carcinoma? Annals of Surgical Treatment and Research, 98, 62-71. [Google Scholar] [CrossRef] [PubMed]
|
|
[27]
|
Lens, S., Rincón, D., García-Retortillo, M., Albillos, A., Calleja, J.L., Bañares, R., et al. (2015) Association between Severe Portal Hypertension and Risk of Liver Decompensation in Patients with Hepatitis C, Regardless of Response to Antiviral Therapy. Clinical Gastroenterology and Hepatology, 13, 1846-1853. [Google Scholar] [CrossRef] [PubMed]
|
|
[28]
|
Yugawa, K., Maeda, T., Nagata, S., Shiraishi, J., Sakai, A., Yamaguchi, S., et al. (2022) Impact of Aspartate Aminotransferase-to-Platelet Ratio Index Based Score to Assess Posthepatectomy Liver Failure in Patients with Hepatocellular Carcninoma. World Journal of Surgical Oncology, 20, Article No. 248. [Google Scholar] [CrossRef] [PubMed]
|
|
[29]
|
Cucchetti, A., Ercolani, G., Vivarelli, M., Cescon, M., Ravaioli, M., La Barba, G., et al. (2006) Impact of Model for End-Stage Liver Disease (MELD) Score on Prognosis after Hepatectomy for Hepatocellular Carcinoma on Cirrhosis. Liver Transplantation, 12, 966-971. [Google Scholar] [CrossRef] [PubMed]
|